These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 26058730)

  • 41. Turoctocog alfa pegol provides effective management for major and minor surgical procedures in patients across all age groups with severe haemophilia A: Full data set from the pathfinder 3 and 5 phase III trials.
    Tosetto A; Neff A; Lentz SR; Santagostino E; Nemes L; Sathar J; Meijer K; Chowdary P; Shen C; Landorph A; Hampton K
    Haemophilia; 2020 May; 26(3):450-458. PubMed ID: 32293786
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Successful perioperative prophylaxis with susoctocog alfa in a patient with acquired haemophilia A: A case study.
    Buczma A; Baran B; Korwin M; Odnoczko E; Windyga J
    Haemophilia; 2022 Mar; 28(2):e39-e41. PubMed ID: 34878208
    [No Abstract]   [Full Text] [Related]  

  • 43. Efficacy, Safety, and Pharmacokinetics of Beroctocog Alfa in Patients Previously Treated for Hemophilia A.
    Hyun SY; Park SY; Lee SY; Kook H; Paik SH; Jang IJ; Lee KS
    Yonsei Med J; 2015 Jul; 56(4):935-43. PubMed ID: 26069114
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Damoctocog Alfa Pegol: A Review in Haemophilia A.
    Paik J; Deeks ED
    Drugs; 2019 Jul; 79(10):1147-1156. PubMed ID: 31218660
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Development of a tail vein transection bleeding model in fully anaesthetized haemophilia A mice - characterization of two novel FVIII molecules.
    Johansen PB; Tranholm M; Haaning J; Knudsen T
    Haemophilia; 2016 Jul; 22(4):625-31. PubMed ID: 26936336
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A post hoc analysis of PROTECT VIII kids assessing long-term efficacy and safety of damoctocog alfa pegol in adolescents with severe haemophilia A.
    Ahuja S; Biss T; Maas Enriquez M; Mancuso ME; Steele M; Kenet G
    Eur J Haematol; 2024 May; 112(5):756-764. PubMed ID: 38193596
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Factor VIII prophylaxis for adult patients with severe haemophilia A: results of a US survey of attitudes and practices.
    Walsh CE; Valentino LA
    Haemophilia; 2009 Sep; 15(5):1014-21. PubMed ID: 19493018
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The immunogenicity, safety, and efficacy of N8-GP in previously untreated patients with severe hemophilia A: pathfinder6 end-of-trial results.
    Kenet G; Young G; Chuansumrit A; Matsushita T; Yadav V; Zak M; Male C
    J Thromb Haemost; 2023 Nov; 21(11):3109-3116. PubMed ID: 37597724
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Therapeutic management and costs of severe haemophilia A patients with inhibitors in Italy.
    Abbonizio F; Giampaolo A; Coppola A; ; Arcieri R; Hassan HJ
    Haemophilia; 2014 Jul; 20(4):e243-50. PubMed ID: 24834967
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Experience with prophylaxis in Sweden.
    Nilsson IM
    Semin Hematol; 1993 Jul; 30(3 Suppl 2):16-9. PubMed ID: 8367738
    [No Abstract]   [Full Text] [Related]  

  • 51. Tranexamic acid in the control of spontaneous bleeding in severe haemophilia.
    Rainsford SG; Jouhar AJ; Hall A
    Thromb Diath Haemorrh; 1973 Nov; 30(2):272-9. PubMed ID: 4773366
    [No Abstract]   [Full Text] [Related]  

  • 52. Arterial pseudoaneurysms in haemophilia: conservative treatment with observation and factor replacement.
    Drew M; Yu JC; Michaels LA
    Haemophilia; 2011 May; 17(3):550-2. PubMed ID: 21118336
    [No Abstract]   [Full Text] [Related]  

  • 53. Octocog alfa (Advate®): a guide to its use in hemophilia A.
    Keating GM; Dhillon S
    BioDrugs; 2012 Aug; 26(4):269-73. PubMed ID: 22759264
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inhibitor development, safety and efficacy of Advate
    Fukutake K; Taki M; Matsushita T; Nogami K; Shima M; Yoshioka A; Takamatsu J; Uchikawa H; Takagi H; Arai M; Engl W; Shirahata A
    Int J Hematol; 2019 Mar; 109(3):336-345. PubMed ID: 30604312
    [TBL] [Abstract][Full Text] [Related]  

  • 55. An overview of the pathfinder clinical trials program: Long-term efficacy and safety of N8-GP in patients with hemophilia A.
    Matsushita T; Mangles S
    J Thromb Haemost; 2020 Sep; 18 Suppl 1(Suppl 1):26-33. PubMed ID: 32558236
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical experience with moroctocog alfa (AF-CC) in younger paediatric patients with severe haemophilia A: Two open-label studies.
    Rusen L; Kavakli K; Korth-Bradley J; Huard F; Rendo P; Fuiman J; Baumann JA; Smith L; Alvey C; Rupon J
    Haemophilia; 2018 Jul; 24(4):604-610. PubMed ID: 29582525
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Rurioctocog alfa pegol PK-guided prophylaxis in hemophilia A: results from the phase 3 PROPEL study.
    Klamroth R; Windyga J; Radulescu V; Collins PW; Stasyshyn O; Ibrahim HM; Engl W; Tangada SD; Savage W; Ewenstein B
    Blood; 2021 Apr; 137(13):1818-1827. PubMed ID: 33150384
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficacy, safety and tolerability of recombinant factor VIII (REFACTO) in patients with haemophilia A: interim data from a postmarketing surveillance study in Germany and Austria.
    Pollmann H; Externest D; Ganser A; Eifrig B; Kreuz W; Lenk H; Pabinger I; Schramm W; Schwarz TF; Zimmermann R; Zavazava N; Oldenburg J; Klamroth R
    Haemophilia; 2007 Mar; 13(2):131-43. PubMed ID: 17286765
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pilot study of once-a-day prophylaxis for youth and young adults with severe haemophilia A.
    Crivianu-Gaita V; Rivard GE; Carcao M; Teitel J; St-Louis J; Blanchette V; Pullenayegum E; Abad A; Feldman BM
    Haemophilia; 2016 Sep; 22(5):e401-5. PubMed ID: 27481574
    [TBL] [Abstract][Full Text] [Related]  

  • 60. BAY 81-8973 demonstrated efficacy, safety and joint status improvement in patients with severe haemophilia A in the LEOPOLD I extension for ≤2 years.
    Mahlangu J; Lopez Fernandez MF; Santagostino E; Lalezari S; Tseneklidou-Stoeter D; Beckmann H; Church N
    Eur J Haematol; 2020 Jun; 104(6):594-601. PubMed ID: 32112434
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.